Navigation Links
Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research

bility, low levels of the enzyme in blood, and low production yields using traditional biotechnology methods. To overcome these limitations, PharmAthene has developed a recombinant form of human BChE, (rBChE), utilizing transgenic expression in goats which enables substantially higher production yields. PharmAthene believes that its transgenic technology will have the capacity to produce sufficient rBChE for both military and civilian defence.

About PharmAthene, Inc.

PharmAthene, a privately-held biotechnology company, was formed to meet the critical needs of the United States by developing biodefense products. PharmAthene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror. PharmAthene's lead programs include Valortim(tm) for the prevention and treatment of anthrax infection and Protexia(r) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit www.PharmAthene.com.


In January 2007, PharmAthene announced that it had signed a definitive merger agreement with Healthcare Acquisition Corp. (AMEX: HAQ). HAQ has filed with the Securities and Exchange Commission a preliminary proxy statement in connection with the proposed merger transaction involving PharmAthene.


HAQ AND ITS DIRECTORS AND EXECUTIVE OFFICERS AS WELL AS PHARMATHENE AND ITS DIRECTORS AND EXECUTIVE OFFICERS MAY BE DEEMED TO BE PARTICIPANTS IN THE SOLICIATION OF PROXIES FOR THE SPECIAL MEETING OF HAQ'S STOCKHOLDERS TO BE HELD TO APPROVE THE PROPOSED MERGER. SECURITYHOLDERS AND OTHER INTERESTED PERSONS ARE URGED TO READ THE PRELIMINARY PROXY STATEMENT REGARDING THE PROPOSED MERGER FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON FEBRUARY 9, 2007 AND THE AMENDMENTS THEREOF AND THE DEFINITIVE PRO
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimers Research
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
4. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
5. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
6. Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007
7. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
8. CuraGen Presents Update on Clinical Development Program for Belinostat
9. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
10. Diatos Announces Positive Clinical Results for its DTS-201 Doxorubicin Prodrug Program
11. OXiGENE Abstracts Published in ASCO Program
Post Your Comments:
(Date:1/6/2009)... of AHCC for maintaining a healthy immune system ,...ently published study in Nutrition and Cancer (6...iversity in Osaka, Japan has shown that AHCC (Acti...ction by increasing the number of dendritic cells ...ponsible for presenting foreign substances to othe...
(Date:1/6/2009).... 6 Sequella, Inc., a c... diseases of epidemic potential, announced today t...nt of tuberculosis (TB), was the first drug approv...ram contract to Dynport Vaccine Company LLC and Qu...e National Institute of Allergy and Infectious Dis...
(Date:1/6/2009)...January 6 , - Ear...ation Until,December 2011 , - Expansion of...y,Discovery in Ophthalmology , - Revised C...n,Sublicenses to a Third Party , ExonHit... reinforcement,of its existing drug discovery col...
(Date:1/5/2009)...., Jan. 5 Women undergoing in vitr...tion to help support early,pregnancy, but the int...ation,can be painful for patients. Formulations ...red by subcutaneous injection or vaginal supposito...tolerance. , With patient well-being a cons...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 476 1SNM applauds NAS study showing need to restore federal nuclear medicine research funding 476 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 476 3Smart insulin nanostructures pass feasibility test UT study reports 1692 1Smart insulin nanostructures pass feasibility test UT study reports 1692 2New research sheds light on Hobbit 475 1New research sheds light on Hobbit 475 2Ancient mechanism for coping with stresses also gives cancer a boost 1686 1Ancient mechanism for coping with stresses also gives cancer a boost 1686 2Ancient mechanism for coping with stresses also gives cancer a boost 1686 3
(Date:1/8/2009)...olo., Jan. 8 Heska Corpo...ebcast: , , , What: Heska Corporation ... Year-End 2008 Earnings Conference Call on ...9:00 a.m. (MST], Where: www.heska.com (cl... Call link on the front page of this website)...
(Date:1/8/2009)...S, Jan. 8 A proposal by...s and Sailors Children,s Home has prompted the 125...to revamp its annual Mid-Winter conference January...its members, nearly unanimous opposition to the pr... more than $50,000 in direct and in-kind support t...
(Date:1/8/2009)...University and Baxter Healthcare Corporation will ... alliance, the two entities announced today. , U...ll fund research-collaboration projects at Northwe...oximately $1 million, and Baxter will determine sp...sis. Aligned with Baxter,s diversified business mo...
(Date:1/8/2009)...EE, Jan. 8 The physicians of North...th clinics in three northern Illinois,communities...a Health Care . , (Photo: http://www.newsc...e five internal medicine physicians serve patients...f Gurnee, Lindenhurst and Fox Lake. , "The ...
Breaking Medicine News(10 mins):Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Baxter and Northwestern University partner to target new life sciences projects 2Health News:Northern Lake Medical to Join Aurora Health Care 2Health News:Northern Lake Medical to Join Aurora Health Care 3
... smoked or barbequed. // A study by American scie...nsumed the most grilled, barbecued or smoked red m...d risk of breast cancer. Big meat-eaters who also ...ercent increased risk of the disease, the scientis...
...neglected yet, crucial issue -dental care insuran...dren do not have access to dental care insurance...for Medicaid, with the poorest children this is of...edicaid, due to its low reimbursement rates. <...
...ing, but only few act. // The explanation, says P..., has two parts. One, human beings get stubbornly ...an species is biologically programmed to act in it... aren't very different from common rats on that po...
...adaches are more than twice as likely to also have...anxiety// than soldiers who do not have migraines,...nited States Army soldiers who were given a health...s after returning from one year of combat duty in ...
Other Medicine News:Health News:Barbeque Lovers Warned To Load On Fruits And Vegetables 2Health News:More Than a Toothache 2Health News:Why Humans Fail to Act on Climate Change 2Health News:Why Humans Fail to Act on Climate Change 3Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2
...Single Head Rectangular Camera ,IS2s Single ...ole body scans and SPECT studies. Offering flexibi...ingle Rectangular Head Camera is an ideal camera f...purpose work, and also acquires excellent cardiac ...
...Arctic Circler uses the same cryoconsole and platf...in the pulmonary veins. Arctic Circler is an ablat...liative-only treatments that rely on medication.,...catheter has the ability to create curvilinear les...
...Aneurysm occlusion is the ultimate objective of ne...num coils. With Matrix Detachable Coils, occlusion...ls are intended for embolization of those intracra..., their location, or the patient's general medical...
Tungsten Carbide wire twister.
Medicine Products: